Loading...

Amplitude Healthcare Acquisition Corporation

AMHCU•NASDAQ
Financial Services
Shell Companies
$10.96
$0.36(3.40%)

Amplitude Healthcare Acquisition Corporation (AMHCU) Stock Overview

Explore Amplitude Healthcare Acquisition Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 69.1/100

Key Financials

Market Cap0
P/E Ratio-216.48
EPS (TTM)N/A
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 Month$16.30
3 Months$11.93
1 Year Target$10.63

AMHCU Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Amplitude Healthcare Acquisition Corporation (AMHCU) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $10.63.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -216.48 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

0.00RSI (14)
0.00MACD
0.00ADX
Stats data is not available for AMHCUStats details for AMHCU are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for AMHCUAnalyst Recommendations details for AMHCU are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Amplitude Healthcare Acquisition Corporation does not have significant operations. It intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination with one or more businesses in the healthcare or healthcare related industries. The company was founded in 2019 and is based in New York, New York.

CEO

Balaji Venkataraman

Employees

1

Headquarters

1177 Avenue of the Americas, New York City, NY

Founded

2019

Frequently Asked Questions

;